A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Chinese Subjects With Moderate to Severe Plaque-type Psoriasis.
Phase of Trial: Phase III
Latest Information Update: 08 Nov 2013
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 05 Mar 2012 Actual start date changed from Nov 2009 to Oct 2009 as reported by ClinicalTrials.gov.
- 05 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2011 Planned End Date changed from 1 Jan 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.